CCAAT/enhancer-binding protein beta deletion reduces adiposity, hepatic steatosis, and diabetes in Lepr(db/db) mice.

MLA

Schroeder-Gloeckler, Jill M., et al. “CCAAT/Enhancer-Binding Protein Beta Deletion Reduces Adiposity, Hepatic Steatosis, and Diabetes in Lepr(Db/Db) Mice.” The Journal of Biological Chemistry, vol. 282, no. 21, May 2007, pp. 15717–29. EBSCOhost, https://doi.org/10.1074/jbc.M701329200.

APA

Schroeder-Gloeckler, J. M., Rahman, S. M., Janssen, R. C., Qiao, L., Shao, J., Roper, M., Fischer, S. J., Lowe, E., Orlicky, D. J., McManaman, J. L., Palmer, C., Gitomer, W. L., Huang, W., O’Doherty, R. M., Becker, T. C., Klemm, D. J., Jensen, D. R., Pulawa, L. K., Eckel, R. H., & Friedman, J. E. (2007). CCAAT/enhancer-binding protein beta deletion reduces adiposity, hepatic steatosis, and diabetes in Lepr(db/db) mice. The Journal of Biological Chemistry, 282(21), 15717–15729. https://doi.org/10.1074/jbc.M701329200

Chicago

Schroeder-Gloeckler, Jill M, Shaikh Mizanoor Rahman, Rachel C Janssen, Liping Qiao, Jianhua Shao, Michael Roper, Stephanie J Fischer, et al. 2007. “CCAAT/Enhancer-Binding Protein Beta Deletion Reduces Adiposity, Hepatic Steatosis, and Diabetes in Lepr(Db/Db) Mice.” The Journal of Biological Chemistry 282 (21): 15717–29. doi:10.1074/jbc.M701329200.